Forma Therapeutics Holdings Inc (FMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FMTX | AZN | AMGN | GILD | VRTX |
| Company | Forma Therapeutics Holdings Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 20.00 | 72.52 | 289.44 | 105.33 | 500.79 |
| High | 20.01 | 72.57 | 290.99 | 105.65 | 504.94 |
| Low | 19.98 | 71.30 | 286.09 | 103.80 | 497.34 |
| Last | 20.01 | 71.54 | 287.39 | 104.45 | 504.83 |
| Change | +0.03 | -0.17 | -1.17 | +0.24 | +1.33 |
| % Change | +0.15% | -0.24% | -0.41% | +0.23% | +0.26% |
| Volume | 739,100 | 736,105 | 348,818 | 1,393,960 | 197,235 |
| 20-Day Average Volume | 898,390 | 6,967,971 | 3,054,401 | 9,604,549 | 1,621,155 |
| Previous Close | 19.98 | 71.71 | 288.56 | 104.21 | 503.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.95 | 68.46 | 286.83 | 105.63 | 487.59 |
| 20-Day Raw Stochastic | 92.86% | 71.13% | 40.63% | 51.66% | 92.93% |
| 20-Day Relative Strength | 84.14% | 52.63% | 46.26% | 46.70% | 56.93% |
| Weighted Alpha | +1.30 | -6.37 | -8.91 | +55.32 | +22.81 |
| Today's Opinion | 100% Buy | 24% Sell | 72% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 24% Sell | 40% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 32% Buy | 100% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 10/06/22 | +4.40% since 04/23/25 | +3.17% since 04/23/25 | -1.85% since 04/23/25 | +2.11% since 04/23/25 |
| Low | 19.95 on 10/07/22 | 68.48 on 04/24/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 484.50 on 04/25/25 |
| High | 20.01 on 10/13/22 | 72.57 on 04/30/25 | 290.76 on 04/30/25 | 107.56 on 04/24/25 | 506.96 on 04/29/25 |
| 1-Month | |||||
| %Chg | +0.35% since 09/13/22 | -3.07% since 03/28/25 | -6.60% since 03/28/25 | -6.60% since 03/28/25 | +2.05% since 03/28/25 |
| Low | 19.88 on 09/23/22 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 20.08 on 09/15/22 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 506.96 on 04/29/25 |
| 3-Month | |||||
| %Chg | +135.69% since 07/13/22 | +0.40% since 01/30/25 | +0.94% since 01/30/25 | +7.70% since 01/30/25 | +14.69% since 01/30/25 |
| Low | 7.24 on 07/26/22 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 446.00 on 02/12/25 |
| High | 20.28 on 09/01/22 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +128.42% since 04/13/22 | -1.79% since 10/30/24 | -9.14% since 10/30/24 | +18.26% since 10/30/24 | +5.83% since 10/30/24 |
| Low | 4.95 on 06/16/22 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 20.28 on 09/01/22 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 957,539 | 222,390,416 | 155,144,576 | 129,758,432 | 129,440,280 |
| Shares Outstanding, K | 47,853 | 3,101,247 | 537,651 | 1,245,163 | 257,081 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -172,960,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 6,667,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -52,578,000 | 1,499,000,000 | 627,000,000 | 1,315,000,000 | 913,000,000 |
| 60-Month Beta | -0.94 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 08/05/22 | 2.49 on 04/29/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 11/11/22 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.01 | 14.28 | 13.74 | 0.00 |